Family Legacy Financial Solutions’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.1M Sell
8,341
-323
-4% -$330K 6.16% 5
2026
Q1
$8.27M Buy
8,664
+56
+0.7% +$56.8K 6.68% 5
2025
Q4
$9.02M Sell
8,608
-175
-2% -$167K 6.95% 4
2025
Q3
$6.7M Buy
8,783
+190
+2% +$141K 5.13% 4
2025
Q2
$6.7M Buy
+8,593
New +$6.68M 5.68% 4

Other funds holding LLY

Family Legacy Financial Solutions's LLY Position: Q2 2026 in Review

Family Legacy Financial Solutions reduced its Eli Lilly (LLY) stake by 3.7% in Q2 2026, selling an estimated $330K and leaving 8,341 shares worth $10.1M. The position accounts for 6.16% of the portfolio, ranked #5.

Family Legacy Financial Solutions first reported a position in LLY in Q2 2025 and has held it in 5 quarters since. 770 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Family Legacy Financial Solutions held 8,341 shares of Eli Lilly worth $10.1M as of Q2 2026.
  • Family Legacy Financial Solutions sold 323 Eli Lilly shares in Q2 2026, an estimated $330K.
  • Eli Lilly made up 6.16% of Family Legacy Financial Solutions's portfolio in Q2 2026, its #5 holding.
  • Family Legacy Financial Solutions first reported a position in Eli Lilly in Q2 2025 and has held it in 5 quarters since.
  • 770 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Family Legacy Financial Solutions's 13F filing for Q2 2026, filed 14 Jul 2026.